The purpose of this investigation was to determine whether blood vessels could develop de novo between an extracardiac artery and a collateral-dependent zone of the heart and to quantify the nutritive blood flow afforded by the new vessels. We also adapted the preparation so that angiogenically active agents could be chronically administered directly to the site of neovascularization in subsequent studies. To induce neovascularization between a systemic artery and the coronary circulation, the left internal mammary artery (IMA) was implanted in an intramyocardial tunnel in proximity to the left anterior descending coronary artery (LAD). A tube situated in the distal IMA connected to an implanted pump provided for continuous intra-arterial infusion at the site of angiogenesis. During the same procedure, an ameroid constrictor was placed on the proximal LAD, rendering its perfusion territory collateral dependent during a 2-3 week period. After 8 weeks, the functional capacity of the anastomoses established between the implanted IMA and the LAD territory was assessed by determining regional myocardial blood flow under basal conditions, during adenosine-induced vasodilatation, and during differential occlusions of the IMA and left circumflex coronary artery (LCCA). For all dogs, IMA occlusion decreased maximal LAD territory flow from 1.31+0.11 to 1.16±0.10 ml/min/g (p<O.OOS). Occlusion of the LCCA decreased LAD zone flow to 0.73 ±0.12 ml/min/g, whereas occlusion of the IMA in addition to the LCCA further decreased LAD zone flow to 0.42+±0.11 ml/min/g (p<0.02). The IMA provided measurable nutritive blood flow in seven of 12 dogs, and in these dogs, the artery provided 30.0+2.5% of total LAD zone collateral conductance under conditions of maximal vasodilatation (range, 23-42%). We conclude that angiogenesis can occur between an implanted internal mammary artery and the native coronary circulation in dogs, providing modest nutritive blood flow to a collateral-dependent region. Further studies will be necessary to determine whether direct, local infusion of angiogenically active factors can enhance neovascularization and whether sufficient flow can be reliably supplied to make some variant of this approach clinically applicable. (Circulation 1990;82:1449-1466 between an independent, unobstructed source of blood flow and the myocardium. In using the former technique, delivery of collateral flow would be limited both by the resistance of the newly formed vessels and by the resistance of the donor artery itself, which would likely be a significant factor in
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Thus, the goals of the present investigation were to determine whether blood vessels could develop de novo between an extracardiac artery and a collateraldependent zone of the heart, to quantify the nutritive blood flow afforded by the new vessels, and to determine its importance relative to that provided by collaterals from native coronary arteries. We also attempted to adapt the preparation so that in subsequent studies, angiogenically active agents could be administered directly to the site of neovascularization over an extended period of time.
In developing such a preparation, we thought that the procedure pioneered by Vineberg6 would provide a reasonable starting point. In this operation, the internal mammary artery (IMA) is tunneled directly into the myocardium with the supposition that anastomoses would form between it and the coronary circulation. By implanting the IMA into the territory of the LAD, and gradually occluding the latter with an ameroid constrictor, an independent artery could be brought into contact with the coronary circulation with the potential, by the process of angiogenesis, to provide nutritional blood flow to a collateral-dependent zone. We devised a method to quantify the collateral blood flow to the territory of the occluded LAD, and determine the relative contributions of the IMA, the left circumflex coronary artery (LCCA) and, by exclusion, all other sources as well. Through a technique based on electrical circuit analyses, we were able to calculate the respective collateral resistances and determine the relations among them.
Methods
This study was undertaken in accordance with the standards set forth by NIH manual 3040-2, "Animal Care and Use in the Intramural Program," and the NIH "Guide for the Care and Use of Laboratory Animals," 1985 edition. It is part of a larger study designed to test the efficacy of a potential angiogenic intervention, which will be presented in a separate communication.
Animals
Thirty-four foxhounds of either sex, age [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] months, weight kg, were used for the studies. Twenty-three animals made up the IMA implanted group (group 1), and eleven dogs constituted the no IMA implanted group (group 2). Group 1 was the control group for a larger investigation designed to study the effects of pharmacological intervention, which will be reported separately.
Surgical Preparation
Prophylactic penicillin (45,000 units/kg i.m.) and gentamicin (4.3 mg/kg i.m.) were given preoperatively. Atropine (0.04 mg/kg i.m.) was administered, and general anesthesia was induced with acepromazine (0.2 mg/kg i.m.), thiamyl sodium (15 mg/kg i.v.), and 0.5-2% inhaled halothane. Dogs underwent thoracotomy through the left sixth intercostal space, and a pericardial cradle was fashioned. The origins of the LAD and LCCA were carefully dissected. A 3-mm ameroid constrictor was placed on the proximal LAD coronary artery, just distal to the first septal perforator. A small polyethylene snare was positioned around the origin of the LCCA.
For group 1 dogs, the left IMA was isolated as a pedicle with its accompanying vein and overlying transversus thoracis muscle, from its origin at the subclavian artery to its bifurcation into the musculophrenic and superior epigastric arteries. After the distal portion of the vessel was doubly ligated and transected, the distal 2-3 cm of the artery was isolated from the pedicle with three or four intercostal branches, which were tied with silk. the distribution of the LAD coronary artery. The free end of the tube was pulled through the tunnel, and the proximal artery was temporarily occluded. The intercostal arteries were cut flush with the surface of the IMA, and a retrograde saline injection through the tube ensured unobstructed flow from all branches. The artery was then pulled into the tunnel and allowed to bleed freely into the myocardium. A 2-3-mm portion of the Silastic tube was allowed to remain in an intramyocardial position in the distal tunnel, which was closed with a purse string suture around the tube. The free end of the tube was connected to an infusion pump (Intermedics Infusaid Corp.), which was implanted subcutaneously in the lateral abdominal wall through a separate incision. Pumps were refilled percutaneously with 0.9% saline at regular intervals, providing continuous flow throughout the duration of the experiment. Models 500, 200, and 400 were used, with reservoirs of 25, 35, and 50 ml, respectively. Depending on the particular pump, flow rate ranged from 0.88 to 2.73 ml/day. Group 2 dogs (no implanted IMA) underwent placement of an ameroid on the LAD, but the IMA was left in situ on the chest wall and was not inserted into the myocardium. A pump was not implanted in the abdominal wall.
Final Study
After 8 weeks, animals in group 1 underwent a terminal study to ascertain the maximal functional capacity of the implanted internal mammary artery with its associated microvasculature. Group 2 dogs underwent a similar study, to determine the maximal collateral flow to the LAD zone. Dogs were anesthetized with morphine sulfate (3.0 mg/kg i.m.) and a-chloralose (80 mg/kg i.v. bolus with 0.25-0.35 mg/kg/min maintenance), and mechanically venti-lated with room air and supplemental oxygen (1-2 1/min) to maintain arterial blood gases in the physiological range. The lead II electrocardiogram was continuously monitored. Fluid-filled catheters were connected to Statham P23Db transducers and inserted into the ascending aorta and left ventricle through the left carotid and left femoral arteries, respectively, for continuous monitoring of aortic and left ventricular pressures. Mean aortic blood pressure was obtained by electronic filtering. The chest was opened in the fourth left intercostal space, and a dual lumen catheter was inserted in the left atrial appendage for infusion of adenosine and tracer microspheres. The proximal portion of the IMA and the LCCA snare were isolated for subsequent occlusions. A catheter was placed in the right femoral artery for withdrawal of microsphere reference blood samples. The dog was anticoagulated with heparin, 5,000 units i.v. followed by a 500 units/hr maintenance drip. Prophylactic lidocaine, 1 mg/kg i.v. was given before the first microsphere injection, followed by a 2-mg/min continuous infusion. An additional 1 mg/kg i.v. dose was administered before occlusions of the LCCA.
Tracer microspheres, 15 gm in diameter, suspended in 10% dextrose with 0.01% Tween-80 were used for the determination of regional myocardial blood flow. Five of six gamma emitting radionuclides were randomly used: 125i 855r (3M Company), 14`Ce, 113Sn, 95Nb, and 46Sc (New England Nuclear). Vials were vortex agitated for 3 minutes, and approximately 1 million microspheres in a volume of 0.4-0.7 ml were diluted with saline to a volume of 2 ml and injected into the left atrial appendage over a 5-10-second period, followed by a 10-ml saline flush. Arterial occlusions were performed 15 After all microsphere blood flow measurements were completed, a square-wave electromagnetic flow probe (model 501, Carolina Medical Electronics, Inc., King, N.C.) was applied to the IMA just proximal to the heart. Basal IMA blood flow was determined after the adenosine infusion was stopped and the heart rate and blood pressure had returned to baseline. The adenosine infusion was resumed, and maximal IMA blood flow was recorded.
In group 2 dogs, microspheres were injected under basal conditions, during adenosine infusion and during adenosine with occlusion of the LCCA.
Animals were killed with an overdose of sodium pentobarbital and potassium chloride. Hearts were fixed for 48-72 hours in 10% buffered formalin, weighed, and cut with a template into seven or eight 7-mm slices parallel to the atrioventricular groove. From the middle four slices, the right ventricle, papillary muscles, and epicardial fat were removed. These were divided into 12 wedges (average mass, 1.34 grams), which were subdivided into endocardial and epicardial portions. Samples were weighed and counted together with the reference blood samples in a well-type Nal multichannel scintillation counter (Packard Autogamma Spectrometer). Counts in the windows of interest corresponding to the peak emissions of each isotope were corrected for background, interchannel crossover, and decay. Myocardial blood flow was calculated according to standard methods.7
Calculation of Collateral Conductance
As a consequence of LAD coronary artery occlusion, several sources of collateral flow potentially develop to the LAD territory: collaterals from the IMA, the LCCA, and other sources, including septal branches of the LAD coronary artery proximal to the ameroid device, branches of the right coronary artery, and endomural vessels from the left ventricular cavity. We thought it essential to calculate each of these vascular resistances specifically because small, but definite, flow contributions from the IMA could be overshadowed by abundant intercoronary anastomoses from the LCCA or other vessels.
By considering the myocardial vascular network as an electrical circuit (Figures 2A and B) , the minimum vascular resistances between each collateral source and the LAD coronary artery bed could be calculated. Quantification of microsphere flow distributed to the LAD and LCCA perfusion zones during conditions of adenosine-induced vasodilatation, with concomitant measurement of arterial blood pressure during the four situations described above (IMA and LCCA patent, IMA occluded and LCCA patent, IMA patent and LCCA occluded, IMA and LCCA occluded) generated four sets of equations that could be solved simultaneously for five resistances of interest: 1) the resistance of IMA related vessels to the LAD perfusion territory, designated RIMA-LAD, 2) the resistance between the LCCA and the LAD territory, termed RLCCA,LAD, 3) the resistance of sources of perfusion to the LAD territory independent of the IMA and the LCCA (i.e., collaterals from the proximal LAD coronary artery, right coronary artery), designated ROTH-LAD, 4 during simultaneous occlusion of the IMA and LCCA. In these cases, it was not possible to distinguish perfusion through the LCCA from perfusion through sources independent of both the IMA and LCCA. Thus, the resistance between all coronary collateral sources and the LAD zone, independent of the IMA, was designated RCOR,LAD, encompassing the resistances RLCCALAD and ROTHLAD in parallel.
In group 2 animals, measurement of microsphere blood flow in the LAD and the control zones before and during LCCA occlusion generated a set of equations that could be solved to determine four resistances: 1) the LCCA to LAD collateral resistance, termed RLCAcLAD, 2) the resistance of all other sources to the LAD territory, independent of the LCCA, defined ROTH,LAD, 3) the resistance of perfusion sources to the control area independent of both the LAD and LCCA, termed RIND, and 4) the control zone arteriolar bed resistance, again defined RNL.
To prevent the potentially confounding effects of autoregulation, maximal coronary vasodilation was induced with an intra-atrial infusion of adenosine, ensuring a linear relation between coronary perfusion pressure and flow.8 All resistances were, therefore, determined at a minimum value dictated by anatomical structure, avoiding potential autoregulatory alterations in arterial resistance and coronary blood flow which might occur in response to LCCA and IMA occlusions.
Reporting of Data
In (1) The eight wedges with the lowest flow ratios were selected to represent the control zone. Then, the mean and standard deviation of the eight flow ratios were calculated, and wedges with flow ratios greater than two standard deviations from the mean of the group were rejected.
For the LAD perfusion territory, we sought to select transmural samples from the central ischemic zone and to reject samples with evidence of subendocardial infarction/fibrosis. Inadvertent inclusion of small portions of normally perfused tissue in purportedly ischemic zone samples due to interdigitating boundaries has been shown to constitute a major source of error in the determination of collateral flow during adenosine-induced vasodilation.9 For this reason, blood flow criteria, rather than anatomic criteria, were used to select homogeneous sample groups representative of the central ischemic zone. Because the LAD coronary artery was occluded, wedges in its perfusion territory exhibited the most compromised vasodilator reserve. Therefore, the LAD zone was preliminarily defined as the group of eight wedges with the lowest flow during adenosine stimulation. Because the IMA could potentially contribute flow to LAD zone samples, the selection was made from flows determined during IMA occlusion. The transmural flow of each wedge was calculated as the weighted average flow of the endocardial and epicardial portions Flow (Wedge)= Inner flowxInner mass+Outer flowx Outer mass Inner mass+Outer mass (2) and the eight wedges with the lowest flow were then preliminarily selected. To exclude wedges with subendocardial fibrosis, the endocardial/epicardial (endo/epi) flow ratio was calculated for each of the eight wedges under basal conditions and compared with the mean endo/epi flow ratio of the group of previously selected control zone wedges, also under basal conditions. Ischemic zone wedges with endo/ epi flow ratios greater than two standard deviations from the mean of the control zone flow ratios were rejected.
Once ischemic zone (IZ) and normal zone (NZ) samples were selected, the average regional flows during each tracer microsphere injection were computed from the inner and outer portions of all of the selected wedges together by the formula:
Mean flow (ml/min/g) = (Mass (g) x Flow (ml/min/g)) >Mass ( Ischemic zone blood flows were also corrected; the same factors that were used to correct NZ blood flows were used to correct IZ blood flows, preserving the IZ/NZ blood flow ratio in each case. For a given isotopic injection, the IZ/NZ blood flow ratio is immune to errors in arterial reference sample collection and real or perceived differences in MAP (as discussed above) and, therefore, is of primary importance in determining the impact of IMA occlusion on IZ blood flow. Thus, the raw IZ flows were normalized by multiplying by the normalized NZ flow and dividing by the unnormalized NZ flow. To continue with the above example, normalized IZ blood flow with the IMA patent would be obtained by multiplying the raw IZ blood flow by the factor 3.90/3.80 (since normalized NZ flow with the IMA patent was increased by this factor). Likewise, normalized IZ blood flow with the IMA occluded would be obtained by multiplying the raw IZ blood flow by the factor 4.29/4.40 (since normalized NZ flow with the IMA occluded was decreased by this factor). In both cases, the IZ/NZ ratio is left unchanged. Unless otherwise stated, the transmural blood flows reported during adenosine infusion before and during IMA occlusion are normalized, and conductance calculations were based on normalized flows. Because LCCA occlusion altered blood flows in both the IZ and NZ, blood flows obtained during LCCA could not be normalized, and the raw blood flow data are reported.
Graphic Representation of Regional Blood Flow
For all dogs, the transmural blood flow for each of the 48 individual wedges was computed during each intervention. The average blood flow per unit myocardial mass was calculated (Equation 2), and graphs of transmural myocardial blood flow versus position were constructed for each of the four slices ( Figures  3A and B) . These graphs were helpful in visually depicting the locations of the ischemic and control zones, gauging the regional flow contributions of the IMA and LCCA, and assessing the consequences of IMA occlusion, with and without concomitant LCCA occlusion. In addition, three-dimensional graphs depicting the location and extent of the IMA flow contribution were generated for each dog ( Figures  4A-M) . For all 48 transmural wedges (96 tissue samples), the blood flows obtained during adenosine stimulation with the IMA occluded were subtracted from the flows obtained with the IMA patent. Subtraction of the two matrices produced a third matrix that provided quantitative spatial information regarding the role of the IMA in individual dogs.
Statistical Analysis
All values are expressed as mean+SEM. Comparisons between two groups were made using two-tailed Student's t tests for paired or unpaired observations, as appropriate. The correlation between IMA blood flow (measured by flowmeter) and the IMA flow ratio was assessed by linear regression analysis with a least-squares method. A p value<0.05 was used to define statistical significance in all cases.
Success of Revascularization
In each dog, the contribution of the IMA to LAD zone perfusion was evaluated by assessing the impact of IMA occlusion on LAD zone flow. Thus, for each of the selected LAD zone wedges, the maximal conductance during adenosine infusion (transmural blood flow per wedge divided by mean arterial pres- another group 1 dog received an inadequate dose of adenosine and was excluded. Data from the 21 remaining animals constitute the basis for this report: 12 group 1 dogs and nine group 2 dogs.
Hemodynamics
Resting heart rate and mean arterial pressure were similar in both groups (Table 1) . Adenosine infusion increased heart rate and decreased blood pressure significantly in both groups, and there were no differences in heart rate or mean arterial pressure during adenosine infusion between the two groups. In group 1 dogs, IMA occlusion did not cause any significant change in either heart rate or mean arterial pressure. Occlusion of the LCCA reduced heart rate and mean arterial pressure in both groups, reaching statistical significance only in group 2. Heart rate and mean arterial pressure obtained during simultaneous IMA and LCCA occlusion in group 1 were not different from measurements obtained during occlusion of the LCCA alone.
Regional Myocardial Blood Flow
Under basal conditions, regional myocardial blood flow was comparable in the two groups, both in the control and LAD zones ( Thus, on average, the IMA provided 10% of maximal 0.42±0.11 ml/min/g (p<0.02, Figure 5B ).
IZ collateral flow, relative to NZ blood flow. Figure 6 ). For any number of resistances in parallel, the reciprocal of the net resistance equals the sum of the reciprocals of the individual resistances. Because conductance is the reciprocal of resistance, the total conductance of parallel sources can be obtained by simple addition. Therefore, total conductance to the ischemic zone=CImALAD+CLccA,La+CoTHLAD, and the proportion of flow arriving at the ischemic zone from each source is directly proportional to its term. For example, the IMA, LCCA, and other sources were of roughly equal importance in providing flow to the ischemic zone in dog 4 (Table 4 , right). In dog 8, the LCCA and other sources each contributed approximately half of the flow to the LAD territory, whereas the IMA provided no flow. The IMA was singularly the most important source of collateral flow to the LAD zone in one of the seven dogs (dog 10). In two, the LCCA was of greatest significance, and in two others, sources independent of the IMA and LCCA were most important. By comparing CIMA,LAD to CCORLAD, the importance of the IMA-derived collateral flow could be gauged relative to the magnitude of the collateral conductance arising from native intercoronary vessels. In the seven dogs with successful IMA to coronary collateral formation ( All values have units of ml * min' * 100g-1 * mm Hg-1. CIMALAD, Conductance from the internal mammary artery to the territory of the left anterior descending coronaiy artery; CIMA-LCCA, Conductance between the internal mammary artery and the left circumflex coronary artery; CCOR LAD, Conductance of all collateral sources to the territory of the left anterior descending coronary artery, independent of the internal mammary artery; CLCCA LAD, Conductance from left circumflex coronary artery to the territory of the left anterior descending coronary artery; COTH-LAD, Conductance of all other collateral sources to the territory of the left anterior descending coronary artery, independent of the left circumflex coronary artery and the internal mammary artery. 21 Given the many variables associated with IMA implantation (surgical preparation of the vessel, its anatomy and the configuration of its side branches, the creation of the tunnel, and the arrangement of the recipient vessels of the LAD territory), it is not surprising that the IMA often failed to provide substantive flow. In many of the dogs with failed implants, subintimal proliferation was noted in the implanted section of the IMA. Systematic, quantitative analysis of the histology at the anastomotic site was not performed, however, and it cannot be determined whether differences in histopathology occurred between grafts that functioned and those that failed. It is unclear whether subintimal proliferation constituted a cause or effect of graft failure. We speculate that the complete lack of neovascularization noted in some dogs resulted from technical factors, and not a failure of angiogenesis per se. This is not a point that can be proven, however, because technical errors can always be invoked in an animal with a failed implant.
For the entire group of dogs with IMA implants (group 1), IMA occlusion decreased maximal IZ flow from 1.31 to 1.16 ml/min/g (p<0.005), and occlusion of the IMA in addition to the LCCA decreased IZ flow from 0.73 to 0.42 ml/min/g (p<0.02). On average, occlusion of the IMA decreased the IZ/NZ blood flow ratio by 10%. Thus, IMA-derived collaterals supplied 10% of maximal IZ blood flow, relative to maximal NZ blood flow. Direct measurement of IMA blood flow by electromagnetic flow probe revealed a mean basal flow of 7.8 ml/min with a mean maximal blood flow of 14.4 ml/min.
Comparing groups 1 and 2, there was no net difference in either basal or maximal IZ flow. Thus, the increment in perfusion provided by the IMA in dogs with implants was offset by a decrease in collateral flow from coronary collaterals, because total flow was the same in both groups. These results are compatible with the hypothesis that regional ischemia provides a stimulus for collateral proliferation that continues until collateral flow is sufficient to meet the metabolic needs of the tissue, at which point the ischemic stimulus is removed and collateral growth ceases. If an independent artery (the IMA) is in contact with the ischemic zone and available as a perfusion source, then angiogenesis can occur, and anastomoses develop between the artery and the coronary circulation. However, in a canine model with single coronary artery occlusion, peak flow will not be improved.
Although the maximal IZ blood flows before and during IMA occlusion are by themselves useful, they may incompletely illustrate the importance of IMAassociated collaterals in an individual dog. For example, the formation of a low-resistance pathway between the IMA and the LCCA (Figure 2A , "Y") may falsely lower the perceived importance of IMAderived IZ flow. The development of such a pathway could result from intrinsic IMA to LCCA collateral formation, or from interconnection of IMAassociated vessels with LCCA to LAD collaterals. When the IMA is occluded and the LCCA is patent, the LCCA provides collateral flow to the IZ not only across "C," but also through "Y', and "X" in series.
As the resistance of "Y" decreases relative to "X,", the impact of IMA occlusion on IZ flow decreases. Thus, the importance of the IMA is more appropriately gauged during LCCA occlusion, at which time the IMA contributes collateral flow both to the IZ and the NZ, through "X" and "Y," respectively. The conductance calculations provide an algebraic solution for the collateral resistances that uniquely predicts both the IZ and NZ blood flows during four separate conditions (differing combinations of perfusion sources and blood pressures, Tables 4 and 5) , and thereby take into account the fact that occlusions affect blood flow in both the LAD and LCCA territories simultaneously. This is illustrated by the data of Table 4 , which provide insight into the relative importance of the contributions of the IMA, the LCCA, and other sources in providing collateral flow to the LAD territory in individual dogs. The IMA provided a variable measure of IZ collateral conductance, providing none in several dogs, but contributing as much as the LCCA in one dog (4) and more than the LCCA in another (10) . These examples illustrate the importance of this technique because this information could not have been derived from the blood flow data alone.
Limitations of Study
Theoretical problems were posed by the limited flow to the LCCA territory during LCCA occlusion. The delivery of greater than 400 microspheres to the LCCA area samples at all times was not practical; therefore, some errors may have occurred in these flow determinations.22 This problem was minimized by averaging the flow from several tissue samples. Thus, the ischemic and control zone flows were computed from the flow of generally eight transmural samples, comprising about 11 grams of tissue, and the standard errors were actually quite small. In calculating the contribution of the IMA to myocardial perfusion, samples from the central ischemic zone, that is the area with the most compromised collateral flow, were used to calculate LAD territory blood flow (i.e., wedges 4, 5, and 6; Figure  3A) . Contributions by the IMA contiguous with its implantation site or at the periphery of the LAD territory (i.e., wedge 3; Figure 3A) were not considered. Therefore, there is the possibility that our data underestimate IMA-dependent, as well as overall, collateral flow.
In summary, this investigation offers direct proof that new vessels can develop between an extracardiac artery and the native coronary circulation, supplying modest but significant nutritive flow to the myocardium. Although neither basal collateral flow nor maximal vasodilator reserve were improved by arterial implantation in this preparation, and the overall failure rate was quite high (42%), it is possible that IMA implantation could add importantly to tissue perfusion if implanted in a region where flow supplied by the native coronary collateral system was inadequate to satisfy the metabolic demands of the myocardium.
Appendix Resistance Calculations
In Figure 2A , the IMA and the LCCA are patent during adenosine infusion. The arteriolar resistances of both the LAD and LCCA arteriolar beds are minimized and assumed to be essentially equivalent, as discussed above. Therefore, they are both denoted "R"'. Because there is no potential across Y, the circuit simplifies to Figure 2B , where X, Z, and C in parallel are represented by "B" Once X is determined, Y and C can be solved bur equations 12 and 13, respectively.
